ESRD Alert: Payment Changes for Dialysis Services — Action by January 1, 2025
Significant changes to ESRD payment rules effective January 1, 2025 require immediate action.
Action required by
January 1, 2025
Review the Action Required section below and ensure your team has completed all compliance steps before this date.
The recent Federal Register Final Rule (Policy ID: FR-2024-25486) outlines significant changes to the Medicare End-Stage Renal Disease (ESRD) Prospective Payment System, which will take effect on January 1, 2025. The revised payment rules will specifically impact reimbursement rates for renal dialysis services, particularly for patients diagnosed with acute kidney injury (AKI). The adjustments aim to better align payment rates with the costs of providing care and to enhance the quality of services delivered to ESRD patients.
What Changed The adjustments in payment rates will likely necessitate a review of existing coding practices to ensure compliance and accurate billing. While specific CPT, HCPCS, or ICD-10 codes affected by these changes are not detailed, clinical coders should refer to the source document for precise coding information. The coverage criteria for renal dialysis services will remain focused on the medical necessity of the treatment, especially for patients with AKI.
Sign in to read the full article
Create a free account to access the complete analysis, action recommendations, and related alert references.
Quick answers
What are the new payment rates for ESRD services?
Specific payment rates are detailed in the source document.
How will these changes affect billing for AKI patients?
Billing practices must be reviewed to align with updated payment rates for AKI.
What documentation is required under the new rules?
Thorough documentation of patient diagnoses and treatment plans is essential.
Content summarized from publicly available federal publications including CMS, MAC contractors, and the Federal Register. CLV Intelligence is not affiliated with or endorsed by any government agency. This is not legal or medical advice.